| Financial Year |
March 31 2023 |
| Monetary Funds |
7,525,787,555.74 |
| Held-for-trading Financial Assets |
20,720.00 |
| Notes Receivable |
1,192,431,425.95 |
| Accounts Receivable |
3,676,328,177.64 |
| Advances to Suppliers |
1,928,435,142.43 |
| Other Receivables |
439,946,190.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
6,845,891.12 |
| Dividend Receivable |
120,000,000.00 |
| Inventories |
8,597,832,556.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
19,477,716.02 |
| Other Current Assets |
422,365,372.30 |
| Total Current Assets |
24,419,797,003.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
39,641,357.36 |
| Long-term Equity Investment |
3,432,641,243.04 |
| Investment Properties |
193,520,129.87 |
| Fixed Assetes |
22,172,405,709.40 |
| Under-construction Projects |
2,418,161,342.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
43,401,521.76 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,371,553,847.78 |
| R&D expenses |
12,519,032.53 |
| Goodwill |
86,713,377.25 |
| Long-Term Deferred and Prepaid Expenses |
827,628,036.80 |
| Deferred Income Tax Assets |
765,067,455.94 |
| Other Non-Current Assets |
17,332,200.00 |
| Sub-Total of Non-Current Assets |
35,301,979,219.89 |
| Total Assets |
59,721,776,223.66 |
| Short-Term Loans |
8,903,552,871.69 |
| Trading Financial liabilities |
21,461,200.00 |
| Notes Payable |
711,521,010.22 |
| Accounts Payable |
6,405,847,302.71 |
| Accounts Received In Advance |
33,347,782.30 |
| Employee Compensation Payable |
511,036,587.97 |
| Taxes Payable |
549,832,664.71 |
| Interest Payable |
30,374,312.81 |
| Dividend Payable |
9,000,000.00 |
| Other payables |
1,403,918,243.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,809,740,208.21 |
| Other Current Liabilities |
289,375,237.51 |
| Sub-Total of Current Liabilities |
26,835,668,907.34 |
| Long-term Loans |
9,312,133,423.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
876,725,088.39 |
| Special Payable |
-- |
| Estimatied Liabilities |
301,104,674.23 |
| Deferred Income Tax Liabilities |
239,294,249.65 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,425,956,299.77 |
| Total Liabilities |
38,261,625,207.11 |
| Paid-In Capital(Or Share Stock) |
1,834,328,747.00 |
| Capital Surplus |
7,298,680,376.62 |
| Surplus Reserve |
511,208,162.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,137,202,666.46 |
| Minority Stockholder's Interest |
3,494,615,880.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,965,535,135.80 |
| Owner's Equity（Stockholder's Equity） |
21,460,151,016.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
59,721,776,223.66 |
